AI Solution Generates Proteins that Bolster Disease Detection
A study detailed an AI-driven advance in biotechnology that bolsters disease detection, drug development, and environmental monitoring.
Read MorePosted by Andy Lundin | Dec 18, 2023 | Diagnostic Technologies |
A study detailed an AI-driven advance in biotechnology that bolsters disease detection, drug development, and environmental monitoring.
Read MorePosted by Andy Lundin | Nov 29, 2023 | Diabetes & Metabolic Diseases |
Researchers developed a device that detects glucose and adenosine monophosphate (AMP) biomarkers in saliva with high sensitivity.
Read MorePosted by Chris Wolski | Nov 24, 2023 | Tuberculosis |
Though without a standard TB diagnosis, guidelines recommend the use of either the TST or IGRAs to test for latent tuberculosis infections.
Read MorePosted by Chris Wolski | Nov 22, 2023 | Disease States |
Metabolic dysfunction-associated steatotic liver disease is estimated to affect about 32.4% of the world’s population.
Read MorePosted by Chris Wolski | Nov 16, 2023 | Diagnostic Technologies |
Consolidation, legislation, new testing types, and a shift to more consumer-driven testing are some clinical laboratory predictions for 2024.
Read More